Browse by Uncontrolled Keywords
Number of items: 9.
A
Atemnkeng, MA;
de Cock, K;
Plaizier-Vercammen, J;
(2007)
Post-marketing assessment of content and efficacy of preservatives in artemisinin-derived antimalarial dry suspensions for paediatric use.
Malaria journal, 6.
p. 12.
ISSN 1475-2875
DOI: https://doi.org/10.1186/1475-2875-6-12
B
Baiden, F;
Owusu-Agyei, S;
Webster, J;
Chandramohan, D;
(2010)
The need for new antibiotics.
Lancet, 375 (9715).
pp. 637-638.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(10)60265-6
Full text not available from this repository.
Behrens, RH;
Awad, AI;
Taylor, RB;
(2002)
Substandard and counterfeit drugs in developing countries.
Tropical doctor, 32 (1).
pp. 1-2.
ISSN 0049-4755
https://researchonline.lshtm.ac.uk/id/eprint/17458
Full text not available from this repository.
F
Fidock, DA;
Rosenthal, PJ;
Croft, SL;
Brun, R;
Nwaka, S;
(2004)
Antimalarial drug discovery: Efficacy models for compound screening.
Nature reviews Drug discovery, 3 (6).
p. 509.
ISSN 1474-1776
DOI: https://doi.org/10.1038/nrd1416
Full text not available from this repository.
H
Hoaglin, DC;
Hawkins, N;
Jansen, JP;
Scott, DA;
Itzler, R;
Cappelleri, JC;
Boersma, C;
Thompson, D;
Larholt, KM;
Diaz, M;
+1 more...
Barrett, A;
(2011)
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
Value in health, 14 (4).
pp. 429-37.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2011.01.011
Full text not available from this repository.
J
Jansen, JP;
Fleurence, R;
Devine, B;
Itzler, R;
Barrett, A;
Hawkins, N;
Lee, K;
Boersma, C;
Annemans, L;
Cappelleri, JC;
(2011)
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: Report of the ISPOR task force on indirect treatment comparisons good research practices: Part 1.
Value in health, 14 (4).
pp. 417-28.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2011.04.002
Full text not available from this repository.
M
Mason, J;
Freemantle, N;
Nazareth, I;
Eccles, M;
Haines, A;
Drummond, M;
(2001)
When is it cost-effective to change the behavior of health professionals?
JAMA, 286 (23).
pp. 2988-2992.
ISSN 0098-7484
DOI: https://doi.org/10.1001/jama.286.23.2988
Musonda, CC;
Little, S;
Yardley, V;
Chibale, K;
(2007)
Application of multicomponent reactions to antimalarial drug discovery. Part 3: Discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro.
Bioorganic & medicinal chemistry letters, 17 (17).
pp. 4733-4736.
ISSN 0960-894X
DOI: https://doi.org/10.1016/j.bmcl.2007.06.070
Full text not available from this repository.
W
Woods, B;
Veenstra, D;
Hawkins, N;
(2011)
Prioritizing pharmacogenetic research: A value of information analysis of CYP2D6 testing to guide breast cancer treatment.
The Cochrane library, 14.
pp. 989-1001.
ISSN 1465-1858
DOI: https://doi.org/10.1016/j.jval.2011.05.048
Full text not available from this repository.